The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3

Matrix Biology

Volumn 28, Issue 8, 2009, Pages 463-469

  Troeberg, Linda ^a   Fushimi, Kazunari ^a   Scilabra, Simone D ^a   Nakamura, Hiroyuki ^a   Dive, Vincent ^b   Thøgersen, Ida B ^c   Enghild, Jan J ^c   Nagase, Hideaki ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b SERVICE DE CHIMIE BIOORGANIQUE ET DE MARQUAGE   (France)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Aggrecanase; Inhibition kinetics; MMPs

Indexed keywords

ADAMALYSIN WITH THROMBOSPONDIN MOTIFS 4; ADAMALYSIN WITH THROMBOSPONDIN MOTIFS 5; ENZYME; MATRIX METALLOPROTEINASE; PROTEOHEPARAN SULFATE; SODIUM CHLORATE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL STRAIN HEK293; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME PURIFICATION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN INTERACTION;

EID: 70449722891     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2009.07.005     Document Type: Article

References (52)

1. Apte S.S., Olsen B.R., and Murphy G. The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J. Biol. Chem. 270 (1995) 14313-14318
2. Baeuerle P.A., and Huttner W.B. Chlorate-a potent inhibitor of protein sulfation in intact cells. Biochem. Biophys. Res. Commun. 141 (1986) 870-877
3. Bieth J.G. Theoretical and practical aspects of proteinase inhibition kinetics meth. Enzymol. 248 (1995) 59-84
4. Bodden M.K., Windsor L.J., Caterina N.C., Harber G.J., Birkedal-Hansen B., and Birkedal-Hansen H. Human TIMP-1 binds to pro-M(r) 92 K GL (gelatinase B, MMP-9) through the "second disulfide knot". Ann. N. Y. Acad. Sci. 732 (1994) 403-407
5. Bond M., Murphy G., Bennett M.R., Amour A., Knauper V., Newby A.C., and Baker A.H. Localization of the death domain of tissue inhibitor of metalloproteinase-3 to the N terminus. Metalloproteinase inhibition is associated with proapoptotic activity. J. Biol. Chem. 275 (2000) 41358-41363
6. Brew K., Dinakarpandian D., and Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta 1477 (2000) 267-283
7. Bury A.F. Analysis of protein and peptide mixtures. Evaluation of three sodium dodecyl sulfate-polyacrylamide gels electrophoresis systems. J. Chromatogr. 213 (1981) 491-500
8. Butler G.S., Apte S.S., Willenbrock F., and Murphy G. Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A and B. Regulation by polyanions. J. Biol. Chem. 274 (1999) 10846-10851
9. Chung L., Shimokawa K., Dinakarpandian D., Grams F., Fields G.B., and Nagase H. Identification of the (183)RWTNNFREY(191) region as a critical segment of matrix metalloproteinase 1 for the expression of collagenolytic activity. J. Biol. Chem. 275 (2000) 29610-29617
10. Clark I.M., and Cawston T.E. Fragments of human fibroblast collagenase. Purification and characterization. Biochem. J. 263 (1989) 201-206
11. Colige A., Ruggiero F., Vandenberghe I., Dubail J., Kesteloot F., Van Beeumen J., Beschin A., Brys L., Lapière C.M., and Nusgens B. Domains and maturation processes that regulate the activity of ADAMTS-2, a metalloproteinase cleaving the aminopropeptide of fibrillar procollagens types I-III and V. J. Biol. Chem. 280 (2005) 34397-34408
12. Fabunmi R.P., Baker A.H., Murray E.J., Booth R.F., and Newby A.C. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells. Biochem. J. 315 Pt 1 (1996) 335-342
13. Fushimi K., Troeberg L., Nakamura H., Lim N.H., and Nagase H. Functional differences of the catalytic and non-catalytic domains in human ADAMTS-4 and ADAMTS-5 in aggrecanolytic activity. J. Biol. Chem. 283 (2008) 6706-6716
14. Gao G., Plaas A., Thompson V.P., Jin S., Zuo F., and Sandy J.D. ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1. J. Biol. Chem. 279 (2004) 10042-10051
15. Gao W., Anderson P.J., and Sadler J.E. Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity. Blood 112 (2008) 1713-1719
16. Gendron C., Kashiwagi M., Lim N.H., Enghild J.J., Thogersen I.B., Hughes C., Caterson B., and Nagase H. Proteolytic activities of human ADAMTS-5: comparative studies with human ADAMTS-4. J. Biol. Chem. 282 (2007) 18294-18306
17. Gerhardt S., Hassall G., Hawtin P., McCall E., Flavell L., Minshull C., Hargreaves D., Ting A., Pauptit R.A., Parker A.E., and Abbott W.M. Crystal structures of human ADAMTS-1 reveal a conserved catalytic domain and a disintegrin-like domain with a fold homologous to cysteine-rich domains. J. Mol. Biol. 373 (2007) 891-902
18. Godyna S., Liau G., Popa I., Stefansson S., and Argraves W.S. Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1. J. Cell Biol. 129 (1995) 1403-1410
19. Hashimoto G., Aoki T., Nakamura H., Tanzawa K., and Okada Y. Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4). FEBS Lett. 494 (2001) 192-195
20. Igarashi T., Oishi Y., Araki S., Mori H., and Takeda S. Crystallization and preliminary X-ray crystallographic analysis of two vascular apoptosis-inducing proteins (VAPs) from Crotalus atrox venom. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun 62 (2006) 688-691
21. Igarashi T., Araki S., Mori H., and Takeda S. Crystal structures of catrocollastatin/VAP2B reveal a dynamic, modular architecture of ADAM/adamalysin/reprolysin family proteins. FEBS Lett. 581 (2007) 2416-2422
22. Itoh Y., Binner S., and Nagase H. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate. Biochem. J. 308 Pt 2 (1995) 645-651
23. Kashiwagi M., Tortorella M., Nagase H., and Brew K. TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J. Biol. Chem. 276 (2001) 12501-12504
24. Kashiwagi M., Enghild J.J., Gendron C., Hughes C., Caterson B., Itoh Y., and Nagase H. Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing. J. Biol. Chem. 279 (2004) 10109-10119
25. Knight C.G., Willenbrock F., and Murphy G. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett. 296 (1992) 263-266
26. Langton K.P., Barker M.D., and McKie N. Localization of the functional domains of human tissue inhibitor of metalloproteinases-3 and the effects of a Sorsby's Fundus Dystrophy mutation. J. Biol. Chem. 273 (1998) 16778-16781
27. Lee M.H., Knäuper V., Becherer J.D., and Murphy G. Full-length and N-TIMP-3 display equal inhibitory activities toward TNF-alpha convertase. Biochem. Biophys. Res. Commun 280 (2001) 945-950
28. Lee M.H., Verma V., Maskos K., Becherer J.D., Knäuper V., Dodds P., Amour A., and Murphy G. The C-terminal domains of TACE weaken the inhibitory action of N-TIMP-3. FEBS Lett. 520 (2002) 102-106
29. Lee M.H., Rapti M., and Murphy G. Total conversion of tissue inhibitor of metalloproteinase (TIMP) for specific metalloproteinase targeting: fine-tuning TIMP-4 for optimal inhibition of tumor necrosis factor-(alpha)-converting enzyme. J. Biol. Chem. 280 (2005) 15967-15975
30. Lee M.H., Atkinson S., and Murphy G. Identification of the extracellular matrix (ECM) binding motifs of tissue inhibitor of metalloproteinases (TIMP)-3 and effective transfer to TIMP-1. J. Biol. Chem. 282 (2007) 6887-6898
31. Maskos K., Fernandez-Catalan C., Huber R., Bourenkov G.P., Bartunik H., Ellestad G.A., Reddy P., Wolfson M.F., Rauch C.T., Castner B.J., Davis R., Clarke H.R., Petersen M., Fitzner J.N., Cerretti D.P., March C.J., Paxton R.J., Black R.A., and Bode W. Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. Proc. Natl Acad. Sci. USA 95 (1998) 3408-3412
32. Matsudaira P. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J. Biol. Chem. 262 (1987) 10035-10038
33. Matthews R.T., Gary S.C., Zerillo C., Pratta M., Solomon K., Arner E.C., and Hockfield S. Brain-enriched hyaluronan binding (BEHAB)/brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member. J. Biol. Chem. 275 (2000) 22695-22703
34. Milla M.E., Leesnitzer M.A., Moss M.L., Clay W.C., Carter H.L., Miller A.B., Su J.L., Lambert M.H., Willard D.H., Sheeley D.M., Kost T.A., Burkhart W., Moyer M., Blackburn R.K., Pahel G.L., Mitchell J.L., Hoffman C.R., and Becherer J.D. Specific sequence elements are required for the expression of functional tumor necrosis factor-alpha-converting enzyme (TACE). J. Biol. Chem. 274 (1999) 30563-30570
35. Morgunova E., Tuuttila A., Bergmann U., and Tryggvason K. Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2. Proc. Natl. Acad. Sci. USA 99 (2002) 7414-7419
36. Mosyak L., Georgiadis K., Shane T., Svenson K., Hebert T., McDonagh T., Mackie S., Olland S., Lin L., Zhong X., Kriz R., Reifenberg E.L., Collins-Racie L.A., Corcoran C., Freeman B., Zollner R., Marvell T., Vera M., Sum P.E., LaVallie E.R., Stahl M., and Somers W. Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5. Protein Sci. 17 (2008) 16-21
37. Murphy G., Willenbrock F., Ward R.V., Cockett M.I., Eaton D., and Docherty A.J. The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem. J. 283 Pt 3 (1992) 637-641
38. Nagase H., Fields C.G., and Fields G.B. Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3). J. Biol. Chem. 269 (1994) 20952-20957
39. Nakada M., Miyamori H., Kita D., Takahashi T., Yamashita J., Sato H., Miura R., Yamaguchi Y., and Okada Y. Human glioblastomas overexpress ADAMTS-5 that degrades brevican. Acta Neuropathol. 110 (2005) 239-246
40. Nakamura H., Fujii Y., Inoki I., Sugimoto K., Tanzawa K., Matsuki H., Miura R., Yamaguchi Y., and Okada Y. Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites. J. Biol. Chem. 275 (2000) 38885-38890
41. Rapti M., Atkinson S.J., Lee M.H., Trim A., Moss M., and Murphy G. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition. Biochem J. 411 (2008) 433-439
42. Safaiyan F., Kolset S.O., Prydz K., Gottfridsson E., Lindahl U., and Salmivirta M. Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate. J. Biol. Chem. 274 (1999) 36267-36273
43. Sarafanov A.G., Ananyeva N.M., Shima M., and Saenko E.L. Cell surface heparan sulfate proteoglycans participate in factor VIII catabolism mediated by low density lipoprotein receptor-related protein. J. Biol. Chem. 276 (2001) 11970-11979
44. Shieh H.S., Mathis K.J., Williams J.M., Hills R.L., Wiese J.F., Benson T.E., Kiefer J.R., Marino M.H., Carroll J.N., Leone J.W., Malfait A.M., Arner E.C., Tortorella M.D., and Tomasselli A. High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2). J. Biol. Chem. 283 (2008) 1501-1507
45. Suzuki K., Kan C.C., Hung W., Gehring M.R., Brew K., and Nagase H. Expression of human pro-matrix metalloproteinase 3 that lacks the N-terminal 34 residues in Escherichia coli: autoactivation and interaction with tissue inhibitor of metalloproteinase 1 (TIMP-1). Biol. Chem. 379 (1998) 185-191
46. Takeda S. Three-dimensional domain architecture of the ADAM family proteinases. Semin. Cell Dev. Biol. (2008)
47. Tortorella M., Pratta M., Liu R.Q., Abbaszade I., Ross H., Burns T., and Arner E. The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage. J. Biol. Chem. 275 (2000) 25791-25797
48. Troeberg L., Tanaka M., Wait R., Shi Y.E., Brew K., and Nagase H. E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A). Biochemistry 41 (2002) 15025-15035
49. Troeberg L., Fushimi K., Khokha R., Emonard H., Ghosh P., and Nagase H. Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases. FASEB J. 22 (2008) 3515-3524
50. Wayne G.J., Deng S.J., Amour A., Borman S., Matico R., Carter H.L., and Murphy G. TIMP-3 inhibition of ADAMTS-4 (Aggrecanase-1) is modulated by interactions between aggrecan and the C-terminal domain of ADAMTS-4. J. Biol. Chem. 282 (2007) 20991-20998
51. Wisniewska M., Goettig P., Maskos K., Belouski E., Winters D., Hecht R., Black R., and Bode W. Structural determinants of the ADAM inhibition by TIMP-3: crystal structure of the TACE-N-TIMP-3 complex. J. Mol. Biol. 381 (2008) 1307-1319
52. Yu W.H., Yu S., Meng Q., Brew K., and Woessner J.F. TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J. Biol. Chem. 275 (2000) 31226-31232